Find and Pitch Jounalists, Get Your Story Covered

Tags: Multiple Myeloma Regimen Comparisons Pharmacist Treatment Selection advice

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs - 3 days ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer - 11 days ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard-of-Care Regimen for Previously Unmanaged CLL - 10 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL - 11 months ago Assessing Clinical Trial Efficacy vs Real-World Effectiveness in the Treatment of Multiple Myeloma - 11 months ago Oncology Pharmacists “Approve Every Regimen That Gets Built Into the Oncology EMR,” yet Pharma Often Overlooks Their Role - about 1 year ago
3	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Daily Oral Edaravone for ALS No Better Than On/Off Regimen - 24 days ago
4	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Treatment Regimen Considerations - about 1 month ago Advancing Treatment Selection in CLL Management - 9 months ago Treatment Opportunities Continue to Advance in CLL Management - 12 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 2 months ago Intermittent Fasting and Meal Replacements Improved Short-Term Glycemia - 4 months ago Better Prevention Strategies Rely on the Monitoring of Outpatient Adverse Drug Events - 4 months ago INHALE-3 Study Data Shows Diabetes Care Is Not “One-Size-Fits-All” - 4 months ago Study: Biosimilar Competition Did Not Consistently Lower Costs for Patients - 7 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 8 months ago Experts Establish First Performance Measures of Lifestyle Medicine Treatments - 8 months ago Study: SB17 Shows Biosimilarity to Ustekinumab for Plaque Psoriasis - 8 months ago STRONG-HF: High-Intensity Care Leads to Higher Doses of Guideline Heart Failure Therapy - 10 months ago Study: Telemonitoring After Heart Failure Comparable to Standard of Care - 11 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - about 1 year ago Study: No Difference Found in Safety of Reference Biologic, Biosimilar - about 1 year ago
6	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	2-Drug Regimen Shows Comparable Effectiveness With 3-Drug Regimen to Treat HIV-1 - 3 months ago Durvalumab Shows Improvements in Overall Survival, Progression-Free Survival for Small Cell Lung Cancer - 7 months ago Dramatic Tumor Regression Was Displayed in New Approach to CAR T Therapy - 8 months ago Researchers Compare Reimbursement and Access to New Treatments in European Lung Cancer Care - 8 months ago
7	Kristen Monaco MedPage Today	Digital Therapies Compared; Summertime Sadness? Spravato Monotherapy Under Review - 4 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 7 months ago Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations - 7 months ago Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care - 10 months ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	'Very Clear Signal' That Survival Improved With Addition of Durvalumab in SCLC - 4 months ago Disparities in PrEP Use Persist - 12 months ago
9	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Team Approach to Meeting REMS Program Requirements - 6 months ago NCCN Guidelines on CDK4/6 Inhibitor Treatment Regimens - about 1 year ago
10	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab - 7 months ago MONALEESA Pooled Analyses Show Quality of Life Is Maintained in Elderly Patients Receiving Ribociclib, Endocrine Therapy - 11 months ago Study Finds IVIG, Therapeutic Plasma Exchange Have Comparable Efficacy for Neurological Disorders - about 1 year ago

Journalists covering Regimen Comparisons